As com­pa­nies dump mon­ey in­to man­u­fac­tur­ing, where will they find the trained work­ers to staff the lines?

With more mon­ey than ever flow­ing through bio­phar­ma, the mas­sive de­mand for scal­able man­u­fac­tur­ing has cre­at­ed a big crunch on find­ing and train­ing a sta­ble …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.